These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38188273)

  • 1. Prevalence of chronic HCV infection in EU/EEA countries in 2019 using multiparameter evidence synthesis.
    Thomadakis C; Gountas I; Duffell E; Gountas K; Bluemel B; Seyler T; Pericoli FM; Kászoni-Rückerl I; El-Khatib Z; Busch M; Schmutterer I; Vanwolleghem T; Klamer S; Plettinckx E; Mortgat L; Van Beckhoven D; Varleva T; Kosanovic Licina ML; Nemeth Blazic T; Nonković D; Theophanous F; Nemecek V; Maly M; Christensen PB; Cowan S; Rüütel K; Brummer-Korvenkontio H; Brouard C; Steffen G; Krings A; Dudareva S; Zimmermann R; Nikolopoulou G; Molnár Z; Kozma E; Gottfredsson M; Murphy N; Kondili LA; Tosti ME; Ciccaglione AR; Suligoi B; Nikiforova R; Putnina R; Jancoriene L; Seguin-Devaux C; Melillo T; Boyd A; van der Valk M; Op de Coul E; Whittaker R; Kløvstad H; Stępień M; Rosińska M; Valente C; Marinho RT; Popovici O; Avdičová M; Kerlik J; Klavs I; Maticic M; Diaz A; Del Amo J; Lundberg Ederth J; Axelsson M; Nikolopoulos G
    Lancet Reg Health Eur; 2024 Jan; 36():100792. PubMed ID: 38188273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B/C in the countries of the EU/EEA: a systematic review of the prevalence among at-risk groups.
    Falla AM; Hofstraat SHI; Duffell E; Hahné SJM; Tavoschi L; Veldhuijzen IK
    BMC Infect Dis; 2018 Feb; 18(1):79. PubMed ID: 29433454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating the scale of chronic hepatitis C virus infection in the EU/EEA: a focus on migrants from anti-HCV endemic countries.
    Falla AM; Ahmad AA; Duffell E; Noori T; Veldhuijzen IK
    BMC Infect Dis; 2018 Jan; 18(1):42. PubMed ID: 29338702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring progress towards elimination of hepatitis B and C in the EU/EEA.
    Sharrock KC; Noori T; Axelsson M; Buti M; Diaz A; Fursa O; Hendrickx G; James C; Klavs I; Korenjak M; Maticic M; Mozalevskis A; Peters L; Rigoni R; Rosinska M; Ruutel K; Schatz E; Seyler T; Veldhuijzen I; Duffell E
    PLOS Glob Public Health; 2022; 2(8):e0000841. PubMed ID: 36962761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating hepatitis B virus prevalence among key population groups for European Union and European Economic Area countries and the United Kingdom: a modelling study.
    Trickey A; Bivegete S; Duffell E; McNaughton AL; Nerlander L; Walker JG; Fraser H; Hickman M; Vickerman P; Brooks-Pollock E; Christensen H
    BMC Infect Dis; 2023 Jul; 23(1):457. PubMed ID: 37430220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current prevalence of chronic hepatitis B and C virus infection in the general population, blood donors and pregnant women in the EU/EEA: a systematic review.
    Hofstraat SHI; Falla AM; Duffell EF; Hahné SJM; Amato-Gauci AJ; Veldhuijzen IK; Tavoschi L
    Epidemiol Infect; 2017 Oct; 145(14):2873-2885. PubMed ID: 28891457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring response to hepatitis B and C in EU/EEA: testing policies, availability of data on care cascade and chronic viral hepatitis-related mortality - results from two surveys (2016).
    Aspinall EJ; Hutchinson SJ; Goldberg DJ; Valerio H; Mozalevskis A; Noori T; Duffell E; Tavoschi L
    HIV Med; 2018 Feb; 19 Suppl 1():11-15. PubMed ID: 29488708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of hepatitis C infection among the general population and high-risk groups in the EU/EEA: a systematic review update.
    Han R; Zhou J; François C; Toumi M
    BMC Infect Dis; 2019 Jul; 19(1):655. PubMed ID: 31337339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus infection in EU/EEA and United Kingdom prisons: opportunities and challenges for action.
    Nakitanda AO; Montanari L; Tavoschi L; Mozalevskis A; Duffell E
    BMC Public Health; 2020 Nov; 20(1):1670. PubMed ID: 33167912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling the impact of incarceration and prison-based hepatitis C virus (HCV) treatment on HCV transmission among people who inject drugs in Scotland.
    Stone J; Martin NK; Hickman M; Hutchinson SJ; Aspinall E; Taylor A; Munro A; Dunleavy K; Peters E; Bramley P; Hayes PC; Goldberg DJ; Vickerman P
    Addiction; 2017 Jul; 112(7):1302-1314. PubMed ID: 28257600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Models of good practice to enhance infectious disease care cascades among people who inject drugs: a qualitative study of interventions implemented in European settings.
    Horváth I; Mårdh O; Schwarz T
    BMC Health Serv Res; 2023 Dec; 23(1):1352. PubMed ID: 38049823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing and Piloting a Standardized European Protocol for Hepatitis C Prevalence Surveys in the General Population (2016-2019).
    Sperle I; Nielsen S; Bremer V; Gassowski M; Brummer-Korvenkontio H; Bruni R; Ciccaglione AR; Kaneva E; Liitsola K; Naneva Z; Perchemlieva T; Spada E; Toikkanen SE; Amato-Gauci AJ; Duffell E; Zimmermann R
    Front Public Health; 2021; 9():568524. PubMed ID: 34123980
    [No Abstract]   [Full Text] [Related]  

  • 13. Changing hepatitis A epidemiology in the European Union: new challenges and opportunities.
    Gossner CM; Severi E; Danielsson N; Hutin Y; Coulombier D
    Euro Surveill; 2015 Apr; 20(16):. PubMed ID: 25953274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Burden of Six Healthcare-Associated Infections on European Population Health: Estimating Incidence-Based Disability-Adjusted Life Years through a Population Prevalence-Based Modelling Study.
    Cassini A; Plachouras D; Eckmanns T; Abu Sin M; Blank HP; Ducomble T; Haller S; Harder T; Klingeberg A; Sixtensson M; Velasco E; Weiß B; Kramarz P; Monnet DL; Kretzschmar ME; Suetens C
    PLoS Med; 2016 Oct; 13(10):e1002150. PubMed ID: 27755545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence and susceptibility to hepatitis A in the European Union and European Economic Area: a systematic review.
    Carrillo-Santisteve P; Tavoschi L; Severi E; Bonfigli S; Edelstein M; Byström E; Lopalco P;
    Lancet Infect Dis; 2017 Oct; 17(10):e306-e319. PubMed ID: 28645862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: The ETHOS Engage study.
    Valerio H; Alavi M; Conway A; Silk D; Treloar C; Martinello M; Milat A; Dunlop A; Murray C; Henderson C; Amin J; Read P; Marks P; Degenhardt L; Stevens A; Prain B; Hayllar J; Reid D; Montebello M; Wade A; Christmass M; Cock V; Dore GJ; Grebely J;
    Int J Drug Policy; 2022 Jul; 105():103706. PubMed ID: 35533635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B and C prevalence and incidence in key population groups with multiple risk factors in the EU/EEA: a systematic review.
    Mason LM; Duffell E; Veldhuijzen IK; Petriti U; Bunge EM; Tavoschi L
    Euro Surveill; 2019 Jul; 24(30):. PubMed ID: 31362808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality from liver diseases attributable to hepatitis B and C in the EU/EEA - descriptive analysis and estimation of 2015 baseline.
    Mårdh O; Quinten C; Amato-Gauci AJ; Duffell E
    Infect Dis (Lond); 2020 Sep; 52(9):625-637. PubMed ID: 32644030
    [No Abstract]   [Full Text] [Related]  

  • 19. Strengthening hepatitis B and C surveillance in Europe: results from the two global hepatitis policy surveys (2013 and 2014).
    Lazarus JV; Mozalevskis A; Safreed-Harmon K; Eramova I
    Hepatol Med Policy; 2016; 1():3. PubMed ID: 30288307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the population impact of hepatitis C direct acting antiviral treatment as prevention for people who inject drugs (EPIToPe) - a natural experiment (protocol).
    Hickman M; Dillon JF; Elliott L; De Angelis D; Vickerman P; Foster G; Donnan P; Eriksen A; Flowers P; Goldberg D; Hollingworth W; Ijaz S; Liddell D; Mandal S; Martin N; Beer LJZ; Drysdale K; Fraser H; Glass R; Graham L; Gunson RN; Hamilton E; Harris H; Harris M; Harris R; Heinsbroek E; Hope V; Horwood J; Inglis SK; Innes H; Lane A; Meadows J; McAuley A; Metcalfe C; Migchelsen S; Murray A; Myring G; Palmateer NE; Presanis A; Radley A; Ramsay M; Samartsidis P; Simmons R; Sinka K; Vojt G; Ward Z; Whiteley D; Yeung A; Hutchinson SJ
    BMJ Open; 2019 Sep; 9(9):e029538. PubMed ID: 31551376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.